JP2023510872A5 - - Google Patents
Info
- Publication number
- JP2023510872A5 JP2023510872A5 JP2022542899A JP2022542899A JP2023510872A5 JP 2023510872 A5 JP2023510872 A5 JP 2023510872A5 JP 2022542899 A JP2022542899 A JP 2022542899A JP 2022542899 A JP2022542899 A JP 2022542899A JP 2023510872 A5 JP2023510872 A5 JP 2023510872A5
- Authority
- JP
- Japan
- Prior art keywords
- molecules
- manipulated
- gene
- mhc
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062960607P | 2020-01-13 | 2020-01-13 | |
| US202062960617P | 2020-01-13 | 2020-01-13 | |
| US62/960,617 | 2020-01-13 | ||
| US62/960,607 | 2020-01-13 | ||
| PCT/US2021/013140 WO2021146222A1 (en) | 2020-01-13 | 2021-01-12 | Modification of blood type antigens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023510872A JP2023510872A (ja) | 2023-03-15 |
| JP2023510872A5 true JP2023510872A5 (cg-RX-API-DMAC7.html) | 2024-01-22 |
| JP7853210B2 JP7853210B2 (ja) | 2026-04-28 |
Family
ID=74562041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542899A Active JP7853210B2 (ja) | 2020-01-13 | 2021-01-12 | 血液型抗原の修飾 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230272429A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4090743A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7853210B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116234906A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021207810A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3164591A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021146222A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11162079B2 (en) | 2019-05-10 | 2021-11-02 | The Regents Of The University Of California | Blood type O Rh-hypo-immunogenic pluripotent cells |
| US20220213434A1 (en) * | 2019-05-10 | 2022-07-07 | The Regents Of The University Of California | Modified pluripotent cells |
| AU2022277931A1 (en) * | 2021-05-19 | 2023-11-30 | Sana Biotechnology, Inc. | Hypoimmunogenic rhd negative primary t cells |
| AU2022325231A1 (en) | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions |
| CA3227108A1 (en) | 2021-08-11 | 2023-02-16 | Xiaomeng HU | Genetically modified primary cells for allogeneic cell therapy |
| WO2023019208A2 (en) * | 2021-08-11 | 2023-02-16 | Sana Biotechnology, Inc. | Engineering cells for cell-based therapies, and associated compositions and methods |
| AU2022326565A1 (en) | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy |
| AU2022325955A1 (en) | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions |
| IL328729A (en) | 2023-12-01 | 2026-07-01 | Sigilon Therapeutics Inc | Methods for producing stem cell-derived islet-like cells, as well as populations and compositions comprising them |
| CN118291605A (zh) * | 2024-04-10 | 2024-07-05 | 深圳市血液中心(深圳市输血医学研究所) | 一种基于ngs的多系统红细胞血型基因分型方法和试剂盒 |
| CN118638907A (zh) * | 2024-06-26 | 2024-09-13 | 中国人民解放军联勤保障部队第九六〇医院 | 一种用于检测易漏检类孟买表型的snp标记 |
| CN119913243A (zh) * | 2025-04-01 | 2025-05-02 | 浙江省血液中心 | Abo血型变异体的snp位点、b亚型变异型血型鉴定试剂盒和方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
| DE19539493A1 (de) | 1995-10-24 | 1997-04-30 | Thomae Gmbh Dr K | Starker homologer Promotor aus Hamster |
| US20140115726A1 (en) | 2011-04-05 | 2014-04-24 | Cellectis | New tale-protein scaffolds and uses thereof |
| WO2014093694A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| PT2931898E (pt) | 2012-12-12 | 2016-06-16 | Harvard College | Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais |
| MX380562B (es) | 2012-12-12 | 2025-03-12 | Broad Inst Inc | Modificaciones de sistemas, métodos y composiciones guía optimizadas para la manipulación de secuencias. |
| KR102955556B1 (ko) | 2012-12-12 | 2026-04-22 | 더 브로드 인스티튜트, 인코퍼레이티드 | 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물 |
| CN105209621B (zh) | 2012-12-12 | 2021-05-25 | 布罗德研究所有限公司 | 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化 |
| EP3294342A4 (en) | 2015-05-08 | 2018-11-07 | President and Fellows of Harvard College | Universal donor stem cells and related methods |
| EP3455635A1 (en) * | 2016-05-13 | 2019-03-20 | The University of Copenhagen | A cell-based array platform |
| KR20240095477A (ko) * | 2017-01-13 | 2024-06-25 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 면역조작된 만능 세포 |
| CN110869494B (zh) | 2017-06-12 | 2025-02-18 | 西奈卫生系统公司 | 无需全身性免疫遏制的同种异体移植物耐受 |
| WO2019084531A1 (en) * | 2017-10-27 | 2019-05-02 | The Children's Hospital Of Philadelphia | MODIFIED RED GLOBES HAVING PHENOTYPES OF RARE ANTIGENS |
| AU2019305585A1 (en) * | 2018-07-17 | 2021-01-28 | The Regents Of The University Of California | Cells differentiated from immunoengineered pluripotent cells |
| EP3824075A4 (en) * | 2018-07-17 | 2022-04-20 | The Regents of The University of California | CHIMERA ANTIGEN RECEPTOR T-CELLS DERIVED FROM IMMUNOMANIPULATED PLURIPOTENTS STEM CELLS |
| US20220213434A1 (en) * | 2019-05-10 | 2022-07-07 | The Regents Of The University Of California | Modified pluripotent cells |
| US11162079B2 (en) * | 2019-05-10 | 2021-11-02 | The Regents Of The University Of California | Blood type O Rh-hypo-immunogenic pluripotent cells |
-
2021
- 2021-01-12 JP JP2022542899A patent/JP7853210B2/ja active Active
- 2021-01-12 US US17/792,121 patent/US20230272429A1/en active Pending
- 2021-01-12 WO PCT/US2021/013140 patent/WO2021146222A1/en not_active Ceased
- 2021-01-12 AU AU2021207810A patent/AU2021207810A1/en active Pending
- 2021-01-12 CA CA3164591A patent/CA3164591A1/en active Pending
- 2021-01-12 CN CN202180022172.7A patent/CN116234906A/zh active Pending
- 2021-01-12 EP EP21704098.9A patent/EP4090743A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lanza et al. | Engineering universal cells that evade immune detection | |
| Gornalusse et al. | HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells | |
| JP2022543112A5 (cg-RX-API-DMAC7.html) | ||
| Sedlik et al. | Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells | |
| JP2024144548A (ja) | Hlaクラスiiタンパク質の発現能を有するhlaクラスii欠損細胞、hlaクラスi欠損細胞、及びその使用 | |
| JP2023002716A (ja) | 主要組織適合遺伝子複合体e分子によって拘束されるt細胞を誘発するサイトメガロウイルスベクター及びhcmvベクターを含む組成物 | |
| Kohn et al. | New frontiers in the therapy of primary immunodeficiency: from gene addition to gene editing | |
| Patel et al. | T-cell therapies for HIV: preclinical successes and current clinical strategies | |
| CN114072516A (zh) | 经修饰的腺病毒 | |
| US9228007B1 (en) | Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells | |
| Esrick et al. | Genetic therapies for sickle cell disease | |
| JP2018076329A (ja) | Cd4+t細胞応答を向上するための修飾されたエピトープ | |
| JP7523357B2 (ja) | ウイルスベクター産生 | |
| CA3164591A1 (en) | Modification of blood type antigens | |
| CN108474003A (zh) | 包含微小rna识别元件的cmv载体 | |
| Levesque et al. | CRISPR-based therapeutic genome editing for inherited blood disorders | |
| Sii-Felice et al. | Innovative Therapies for Hemoglobin Disorders: K. Sii-Felice et al. | |
| JP7714667B2 (ja) | 改変ヒト人工多能性幹細胞の製造方法 | |
| Sheppard et al. | Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication | |
| Hotblack et al. | Dendritic cells cross-present immunogenic lentivector-encoded antigen from transduced cells to prime functional T cell immunity | |
| AU2020370254B2 (en) | Transgenic swine, methods of making and uses thereof, and methods of making human immune system mice | |
| Porteus | Knock-in editing: it functionally corrects! | |
| Rans et al. | The evolution of gene therapy in X-linked severe combined immunodeficiency | |
| Kaneko et al. | Uphill Battle of CRISPR/Cas9: A Budding Technology in Need of Refinement | |
| 栗原健 | Suppression of HBV replication by the expression of nickase-and nuclease dead-Cas9 |